Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (48)
  • Open Access

    VIEWPOINT

    MSCs-exosomes in regeneration medicine: Current evidence and future perspectives

    BENSHUAI YOU1, HUI QIAN1,2,*

    BIOCELL, Vol.46, No.6, pp. 1459-1463, 2022, DOI:10.32604/biocell.2022.018378 - 07 February 2022

    Abstract Exosomes, especially from mesenchymal stem cells, have attracted extensive attention in regeneration medicine. Mesenchymal stem cells derived exosomes (MSCs-exosomes) have shown anti-inflammatory, anti-oxidant, anti-apoptosis and tissue regeneration effects in a variety of tissue injury repair models. MSCs-exosomes hold many excellent properties such as low immunogenicity, biocompatibility, and targeting capability. With the in-depth study on the generation and function of exosomes, MSCs-exosomes are considered to be the bright stars in the field of regenerative medicine. However, there are still many obstacles to overcome in terms of exosomes isolation, clinical trials and safety evaluation. In this article, More >

  • Open Access

    ARTICLE

    Mesenchymal stem cell-derived exosome: The likely game-changer in stem cell research

    DICKSON KOFI WIREDU OCANSEY1,2,*, XINWEI XU1, LU ZHANG1, FEI MAO1,*

    BIOCELL, Vol.46, No.5, pp. 1169-1172, 2022, DOI:10.32604/biocell.2022.018470 - 06 January 2022

    Abstract Stem cell research is a promising area of transplantation and regenerative medicine with tremendous potential for improving the clinical treatment and diagnostic options across a variety of conditions and enhancing understanding of human development. Over the past few decades, mesenchymal stem cell (MSCs) studies have exponentially increased with a promising outcome. However, regardless of the huge investment and the research attention given to stem cell research, FDA approval for clinical use is still lacking. Amid the challenges confronting stem cell research as a cell-based product, there appears to be evidence of superior effect and heightened… More >

  • Open Access

    RETRACTION

    Retraction: M1 macrophage-derived exosomes moderate the differentiation of bone marrow mesenchymal stem cells

    TAILIN WU1,#; XIANG ZHOU2,#; CANHUA YE1; WENCAN LU1; HAITAO LIN1; YANZHE WEI1; ZEKAI KE1; ZHENGJI HUANG1; JIANZHOU LUO1; HUIREN TAO1; CHUNGUANG DUAN1,*

    BIOCELL, Vol.46, No.4, pp. 1123-1123, 2022, DOI:10.32604/biocell.2022.020679 - 15 November 2021

    Abstract This article has no abstract. More >

  • Open Access

    VIEWPOINT

    Stem cells in intervertebral disc regeneration–more talk than action?

    PETRA KRAUS1,*, ANKITA SAMANTA1, SINA LUFKIN2, THOMAS LUFKIN1

    BIOCELL, Vol.46, No.4, pp. 893-898, 2022, DOI:10.32604/biocell.2022.018432 - 15 December 2021

    Abstract Pain and lifestyle changes are common consequences of intervertebral disc degeneration (IVDD) and affect a large part of the aging population. The stemness of cells is exploited in the field of regenerative medicine as key to treat degenerative diseases. Transplanted cells however often face delivery and survival challenges, especially in tissues with a naturally harsh microniche environment such as the intervertebral disc. Recent interest in the secretome of stem cells, especially cargo protected from microniche-related decay as frequently present in degenerating tissues, provides new means of rejuvenating ailing cells and tissues. Exosomes, a type of More >

  • Open Access

    VIEWPOINT

    Controversies in therapeutic application of mesenchymal stem cell-derived secretome

    FERENC SIPOS*, GYÖRGYI MŰZES

    BIOCELL, Vol.46, No.4, pp. 903-906, 2022, DOI:10.32604/biocell.2022.018200 - 15 December 2021

    Abstract Though mesenchymal stem cells (MSCs) are considered as an important pillar of regenerative medicine, their regenerative potential has been shown to be limited in several pathological conditions. The adverse properties of MSC-based cell therapy have drawn attention to the therapeutic use of MSC-derived secretome. However, MSC-originated exosomes and microvesicles can also possess a significant impact on disease development, including cancer. By interchanging secretome, MSCs can interact with tumor cells and promote mutual exchange/induction of cellular markers. In addition, enzymes secreted into and activated within exosomes can result in the acquisition of new tumor cell properties. More >

  • Open Access

    REVIEW

    The effect of exosomes in transferring TET signaling alterations

    SERGIU PASCA1,*, ANCUTA JURJ2

    BIOCELL, Vol.46, No.3, pp. 579-581, 2022, DOI:10.32604/biocell.2022.017926 - 18 November 2021

    Abstract Ten eleven translocation (TET) enzymes are composed of three representatives: TET1/2/3 which are involved in the hydroxymethylation of methylated cytosines. Because of the wide array of processes that are governed by these epigenetic marks, there have been a wide range of clinical effects associated with TET alterations. Even though many research groups have focused on analyzing the effect of TET alterations within certain cells, few have taken into consideration the effect of TET in the context of intercellular communication. One important entity through which intercellular communication occurs is represented by exosomes. Thus, in the current More >

  • Open Access

    ARTICLE

    A549/DDP derived exosomes can affect cisplatin chemosensitivity via transporting CXCR4 to A549 cells

    MINGMING FANG1,#, NING GE2,#, JIANFANG LIU3,*, YAYUN CUI2,*

    BIOCELL, Vol.46, No.3, pp. 711-720, 2022, DOI:10.32604/biocell.2022.016714 - 18 November 2021

    Abstract The resistance of cancer cells to the anti-cancer drugs is the most important reason that affecting the efficacy of the non-small cell lung cancer (NSCLC) chemotherapy; thus, to explore the underlying mechanism of drug resistance of NSCLC medications is urgently needed for improving the therapeutic efficacy of current anti-NSCLC chemotherapies. The aim of the present study is to explore the roles of exosomes in the chemosensitivity of A549 cells and the related mechanism. A549 cells and cisplatin resistant cell line A549/DDP derived exosomes were isolated, and the expressions of CXCR4 were compared. Then, after cisplatin… More >

  • Open Access

    ARTICLE

    M1 macrophage-derived exosomes moderate the differentiation of bone marrow mesenchymal stem cells

    TAILIN WU1,#, XIANG ZHOU2,#, CANHUA YE1, WENCAN LU1, HAITAO LIN1, YANZHE WEI1, ZEKAI KE1, ZHENGJI HUANG1, JIANZHOU LUO1, HUIREN TAO1, CHUNGUANG DUAN1,*

    BIOCELL, Vol.46, No.2, pp. 495-503, 2022, DOI:10.32604/biocell.2022.015214 - 20 October 2021

    Abstract Differentiated macrophages have been proven to participate in the development of mesenchymal stem cells in different tissues. However, the regulatory processes remain obscure. Exosomes, which are key secretions of macrophages, have attracted increasing attention. Therefore, macrophage-derived exosomes may modulate the development of Bone marrow mesenchymal stem cells (BMMSCs). Different culture conditions were used to induce M1 polarization in THP1 cells. Subsequently, exosomes derived from unpolarized (M0) and polarized (M1) macrophages were isolated, BMMSCs were cultured with normal complete medium or inductive medium supplemented with M0 or M1 derived exosomes, and the osteogenic capacity of the… More >

  • Open Access

    ARTICLE

    Lysophosphatidylcholine acyltransferase 1 is involved in the regulation of exosome secretion and uptake in colorectal cancer cells

    HAIZHENG LIU1, SHAOFEI CHANG2,*

    BIOCELL, Vol.46, No.2, pp. 453-462, 2022, DOI:10.32604/biocell.2021.015340 - 20 October 2021

    Abstract Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is a phospholipid acyltransferase that promotes phospholipid synthesis and plasma membrane reconstruction. Exosomes play an important role in tumor metastasis. The release and uptake of exosomes are key steps of their functions and depend on plasma membrane fusion and plasma membrane receptors, respectively. The purpose of this study was to explore whether LPCAT1-induced plasma membrane remodeling would change the secretion and uptake behavior of exosomes in tumor cells. We first confirmed the abnormally high expression of LPCAT1 in colorectal cancer cells by quantitative real-time PCR (qPCR) and Western blot analysis. Then,… More >

  • Open Access

    ARTICLE

    Revisiting miR-155 in intervertebral disc degeneration: blood cell signature and local cell-free profiles

    ZHIHENG LIU1,2, ZHEN SUN3, ZHONGYUAN WAN4, HAIQIANG WANG2,*

    BIOCELL, Vol.46, No.2, pp. 511-517, 2022, DOI:10.32604/biocell.2021.016194 - 20 October 2021

    Abstract We unraveled the expression profiles of coding-noncoding RNAs in intervertebral disc degeneration (IDD). However, it remains elusive regarding miR-155 expression in peripheral blood mononuclear cells (PBMCs) and local extracellular space in IDD. The study aimed for investigating the miR-155 expression of PBMCs, extracellular miRNAs (ex-miRNAs) of human nucleus pulposus (NP) tissues, and morphological changes of cell death in the IDD process. Here, we harvested peripheral blood and NP samples from scoliosis and IDD patients as control and degenerative groups, respectively. Then standard Ficoll density-gradient centrifugation was used to isolate PBMCs. The two subpopulations of PBMCs… More >

Displaying 31-40 on page 4 of 48. Per Page